ArticleFrontiers in surgery2025
Development and validation of a practical prediction model for post-ERCP pancreatitis using machine learning.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-Based Prediction of Post-ERCP Pancreatitis: A Comparative Study Using Tabular, Image, and Multimodal Data.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is one most frequent and severe complication of ERCP. In consideration of recent advancements in both endoscopic and artificial intelligence research, it is possible to construct a practical risk prediction model to facilitate the identification of PEP patients at elevated risk. Aim: We developed and validated a concise predictive model for post-ERCP pancreatitis risk with logistic regression (LR), LightGBM, Support Vector Machine (SVM), XGBoost, and Multilayer Perceptron (MLP) neural network models. Methods: We selected 688 patients undergone ERCP to form the basic dataset, with 70% for training and 30% for validation. Subsequently, Stepwise Backward Selection Based on Logistic Regression was utilized to select pertinent clinical features, incorporating the machine learning (ML) models to construct the final predictive model. The efficacy of the model was evaluated by various metrics. These newly identified clinical features were then incorporated into a simplified, points-based risk scoring system for potential bedside application and further evaluation. Results: Based on the collected data and the results of stepwise backward regression, we identified the following features as potentially significant clinical variables that influence the risk of post-ERCP pancreatitis: periampullary diverticulum, pancreatic stent placement, pancreatic guidewire passages, dilation of the extrahepatic bile duct, age, and coronary artery disease, and constructed a prediction model. Following this, several ML models were constructed to assess the performance of this model. All ML models demonstrated superior performance to conventional logistic regression (LR) models in terms of AUC curves, with XGBoost, SVM, LightGBM, and MLP models all achieving at least acceptable performance levels. Finally, we developed a simplified scoring system based on LightGBM model with an AUC of 0.75. Conclusions: We developed and validated a concise predictive model for post-ERCP pancreatitis risk, and a simplified scoring system based on the LightGBM model. This model facilitates individual risk prediction and preventive strategy selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.